aTyr Pharma, Inc.

ATYR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 May 13, 2026 4
4 May 13, 2026 4
8-K May 11, 2026 8-K
ARS Mar 26, 2026 ARS
DEFA14A Mar 26, 2026 DEFA14A
SCHEDULE 13G/A Mar 26, 2026
DEF 14A Mar 26, 2026 DEF 14A
PRE 14A Mar 12, 2026 PRE 14A
10-K Mar 5, 2026 10-K
8-K Mar 5, 2026 8-K
4 Feb 4, 2026 4
4 Feb 4, 2026 4
4 Feb 4, 2026 4
4 Jan 9, 2026 4
4 Jan 9, 2026 4
4 Jan 9, 2026 4
8-K Dec 5, 2025 8-K
10-Q Nov 6, 2025 10-Q
8-K Nov 6, 2025 8-K
4 Oct 9, 2025 4
SCHEDULE 13G/A Oct 7, 2025
8-K Sep 15, 2025 8-K
EFFECT Aug 18, 2025
CORRESP Aug 13, 2025
UPLOAD Aug 13, 2025
← Newer Page 2 of 30 · 750 filings Older →